Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-23

Clinical Trial Update: The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating whether adding growth hormone improves outcomes in assisted reproductive technology for poor responders with low ovar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Low Ovarian Reserve | Phase 4 | Status: UNKNOWN